Beginning July 1, 2026, the Centers for Medicare & Medicaid Services (CMS) will launch the Medicare GLP-1 Bridge, a demonstration program that will allow eligible Medicare beneficiaries to access certain GLP-1 medications for a flat $50 monthly copay.